Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions
Recruiting
The goal of the Potenza device used in this study is to collect clinical data for dermatologic conditions in which electrocoagulation and hemostasis is a viable mechanism for means of improvement.
Gender:
ALL
Ages:
Between 22 years and 65 years
Trial Updated:
05/03/2024
Locations: Cynosure, Inc., Westford, Massachusetts
Conditions: Wrinkle, Fine Lines, Crepey Skin, Acne Scars, Active Acne, Enlarged Pores, Stretch Mark, Loose Skin
Virtual Reality Based Rehabilitation After Ischemic Stroke
Recruiting
Use the template below as a guide to write a brief study description in plain language. Tailor the text that appears in brackets and yellow to your research study. To finalize, delete the text in italics. The goal of this single-arm study is to explore the use of early virtual reality-based rehabilitation as an adjunct to conventional physical/occupational therapy in adult patients with acute ischemic stroke. The main question it aims to answer is: Feasibility and tolerability of using immersi... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/03/2024
Locations: Stony Brook University Hospital, Stony Brook, New York
Conditions: Ischemic Stroke
Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy
Recruiting
In order to examine the effect of GH on adipose tissue inflammation, this study will examine adipose tissue and serum inflammation in patients with GH deficiency before and after GH therapy. The investigators will also obtain serum samples before and after treatment for adipokines, inflammatory markers and examine macrophages in circulation with regard to their inflammatory state. The investigators will also obtain adipose tissue biopsies from healthy subjects matched to the growth hormone defic... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
05/03/2024
Locations: Neuroendocrine Unit and Pituitary Center, Columbia University, New York, New York
Conditions: Growth Hormone Deficiency
Sham LaserCap vs. LaserCap SD vs. LaserCap HD+
Recruiting
Androgenetic alopecia (AGA) is a prevalent disease, occurring in 80% of Caucasian men and 50% of Caucasian women by age 701. Treatments for AGA are limited, and presently the only FDA-approved medications for AGA are topical minoxidil and oral finasteride1. In addition to medical therapies, FDA-cleared medical devices are now utilized for the treatment of AGA as of 20072. These devices, termed low level laser therapy (LLLT), come in multiple forms including combs, helmets and sports cap wearabl... Read More
Gender:
ALL
Ages:
25 years and above
Trial Updated:
05/03/2024
Locations: Banner University Dermatology, Tucson, Arizona
Conditions: Androgenetic Alopecia
Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas
Recruiting
This study is being conducted to evaluate the safety and efficacy of the combination of pemetrexed and zanubrutinib (called induction therapy) followed by zanubrutinib treatment alone (also called maintenance therapy) in people who have relapsed or refractory (RR) primary central nervous system lymphoma (PCNSL) or isolated central nervous system relapse of B cell lymphoma (SCNSL). Assessments include how well people respond to this treatment, whether their disease gets better or worse, and their... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/03/2024
Locations: Miami Cancer Institute at Baptist Health, Inc., Miami, Florida
Conditions: Primary Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma, Relapsed Cancer, Refractory Cancer
The Impact of Expressive Emotional Writing on Facilitating Grief Resolution in Adults With Spinal Cord Injury
Recruiting
The aim of this study is to evaluate the therapeutic benefits of a 10-week online coach-guided EEWP on psychosocial health among adults with SCI.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/03/2024
Locations: University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Spinal Cord Injuries, Transverse Myelitis
Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers
Recruiting
This study is a prospective, multi-center, randomized controlled trial designed to collect patient outcome data on 2 commercially available SOC treatments for Diabetic Foot Wounds.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/03/2024
Locations: LA Foot and Ankle, Los Angeles, California +14 locations
Conditions: Diabetic Foot Ulcer, Ulcer Foot, Diabetic Foot
Body Composition and Adipose Tissue in HIV
Recruiting
In this study, the investigators will examine the effect of therapy with the Growth Hormone Releasing Hormone (GHRH) analog tesamorelin on body composition in patients with HIV lipodystrophy and central adiposity. This study is a single arm prospective study of tesamorelin therapy of patients with HIV lipodystrophy. Subjects will do body composition testing, adipose tissue biopsy, metabolic rate measurements and insulin sensitivity assessment before, 6 and 12 months after daily injections of tes... Read More
Gender:
ALL
Ages:
Between 18 years and 68 years
Trial Updated:
05/03/2024
Locations: Neuroendocrine Unit and Pituitary Center, Columbia University, New York, New York
Conditions: HIV Lipodystrophy Syndrome, Growth Hormone Deficiency, Body Composition
Harnessing Telemedicine to Improve Alcohol Use Disorder Outcomes in Primary Care Patients
Recruiting
The purpose of this trial is to test new programs to see if they might help people manage their health and health behaviors related to alcohol use and well-being. The program sessions focus on getting to know what's important to the participants, reviewing or setting goals, and using different skills and behaviors to better manage health. The trial will help the study team learn about ways to deliver health information in a way that is useful and interesting. This research will take place remot... Read More
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
05/03/2024
Locations: VA Ann Arbor Health Care | Veterans Affairs, Ann Arbor, Michigan +1 locations
Conditions: Substance Use Disorders, Substance Use, Substance Dependence
Fatigability in Long COVID-19
Recruiting
The overall goal of this project is to advance the understanding of underlying mechanisms impacting performance fatigability and perceived fatigability in Veterans with post-COVID-19 fatigue and explore the safety and feasibility of a home-based "minimal-dose" resistance exercise program in this population. The central hypothesis is that declines in force capacity, skeletal muscle oxygen extraction, and affective responses to physical activity offer potential mechanisms through which fatigabilit... Read More
Gender:
ALL
Ages:
50 years and above
Trial Updated:
05/03/2024
Locations: Washington DC VA Medical Center, Washington, DC, Washington, District of Columbia
Conditions: Long COVID
REHAB Fontan Failure: A Trial of Cardiac Rehabilitation
Recruiting
The goal of this clinical trial is to compare the impact of cardiac rehabilitation on Fontan failure patients' exertional tolerance, frailty, and quality of life. 1. Among patients with Fontan failure, will cardiac rehabilitation increase average daily steps compared to usual care? 2. Among patients with Fontan failure, will cardiac rehabilitation improve exertional tolerance (as measured by cardiopulmonary exercise testing), frailty, and self-reported quality of life metrics compared to usual... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/03/2024
Locations: Stanford University, Stanford, California +1 locations
Conditions: Heart Failure Congenital, Single-ventricle
Immunization With BCG Vaccine to Prevent Tuberculosis Infection
Recruiting
The purpose of this research is to find out if a single dose of pre-travel vaccination with BCG can lessen tuberculosis (TB) infection by producing an immune response when given to adults traveling to countries with a high burden of TB. BCG will be compared with a placebo (an inactive vaccine). BCG (Japan) is used globally but is not approved for use in the United States, therefore it is considered experimental. Participants choosing to take part in this research study, will be randomly assigned... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
05/02/2024
Locations: Yale University School of Medicine, New Haven, Connecticut +5 locations
Conditions: Tuberculosis Infection